RCAR - RenovaCare, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

RenovaCare, Inc.

Pittsburgh Life Sciences Greenhouse
2425 Sidney Street
Pittsburgh, PA 15203
United States
888-398-0202
http://www.renovacareinc.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas BoldPres, Interim CFO & Director100kN/A1961
Ms. Patsy J. TrislerVP of Regulatory & Clinical Affairs60kN/A1948
Mr. Harmel S. RayatFounder, Chairman & Interim CEON/AN/A1961
Mr. Jatinder Singh BhogalChief Operating OfficerN/AN/A1967
Dr. Roger Esteban-VivesDirector of Cell SciencesN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Pittsburgh, Pennsylvania.

Corporate Governance

RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.